View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Selpercatinib 160, Non-Small Cell Lung Cancer, adjuvant
Protocol-ID: 3231 V1.0 (Mini), SELP160, NSCLC, adj.Indication(s)
- Lung Carcinoma, Non-Small Cell; ICD-10 C34.-
RET fusion positive
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. |
Valid since: 07.08.2026